Over the course of the past week or so, the Auris Medical Holding Ltd (NASDAQ: EARS) stock has emerged as one of the major gainers and the rally continued on Tuesday.
Yesterday, the stock soared by as high as 52% and took the total gains for the past week to 85%. While the gains made by the Auris stock are eye-catching, it is also necessary to point out that there has been no news about the company that could have brought about such gains in recent days.
In such a situation, it might be a good idea to take a closer look at the company and its business. The company is already designated as a clinical-stage operator and is engaged in the development of products for medical needs that remain unmet. The company, which was established in 2003, currently has a range of products in its pipeline and some of the products are meant for vertigo, allergens, and weight gain among others.